课题基金 / 基金详情

Development of therapeutics for prevention and treatment of pre-eclampsia: One of the leading causes of preterm birth in Canada.

Development of therapeutics for prevention and treatment of pre-eclampsia: One of the leading causes of preterm birth in Canada.
预防和治疗先兆子痫的疗法的开发：加拿大早产的主要原因之一。
批准号：
351101
负责人：
Smith Graeme N
金额：
$14.49万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-08-01 至 2018-08-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=351101&lang=en
关键词：
Epigenetics Fetus And Growth Restriction Heart Disease Pregnancy And Pre-Eclampsia Women

项目摘要

项目成果

Smith Graeme N的其他基金

相关文献

中文摘要
翻译
先兆子痫是一种妊娠期高血压疾病，在过去的30年里频率一直在增加。它也是加拿大和全世界婴儿和母亲早产和不良结局的主要原因之一。治疗我们
英文摘要
Pre-eclampsia, a high blood pressure disorder in pregnancy, has been increasing in frequency over the last thirty years. It is also one of the leading causes of premature birth and poor outcome for babies and mothers in Canada and worldwide. Treatment us
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiac and vasculoendothelial assessment following a pre-eclamptic pregnancy.
Pregnancy Complications Identify Women at Risk for Developing Cardiovascular Disease.
Improving Long-Term Maternal Health
Pregnancy complications identify women at risk for developing cardiovascular disease